RekrutujeFaza II/III
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Miasta: Gdańsk, Kielce, Kraków, Lublin i 6 innych miastWiek: od 18 latSponsor: Mirati Therapeutics Inc.
RekrutujeFaza II
Pan Tumor Rollover Study
Miasta: Biała Podlaska, Bydgoszcz, Gdańsk, Kraków i 6 innych miastWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company
RekrutujeFaza III
A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include…
Miasta: Białystok, Brzeziny, Bydgoszcz, Gdańsk i 11 innych miastWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
Rekrutacja wkrótceFaza II
A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis
Miasta: Bydgoszcz, Lublin, Olsztyn, ŁódźWiek: od 18 latSponsor: Agomab Spain S.L.U.
Rekrutacja wkrótceFaza III
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Miasta: Białystok, Bydgoszcz, Gdańsk, Olsztyn i 1 inne miastoWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company
Rekrutacja wkrótceFaza III
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in…
Miasta: Olsztyn, Poznań, WarszawaWiek: od 18 latSponsor: AstraZeneca AB